Premium
OTPs in NY to help study telemedicine to treat hepatitis C
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32432
Subject(s) - telemedicine , opioid use disorder , hepatitis c , medicine , hepatitis c virus , covid-19 , medical emergency , virology , opioid , virus , health care , political science , receptor , law , disease , infectious disease (medical specialty)
Seven opioid treatment programs (OTPs) at 12 locations in New York state will participate in a study that uses telemedicine to integrate the treatment of opioid use disorder (OUD) and hepatitis C virus (HCV). The goal is to achieve better outcomes by delivering HCV treatment on‐site via telemedicine, instead of referring out. It makes sense that this would be more effective than sending patients elsewhere, but the study needs to be done.